MoneyWorks4Me

Anuh Pharma informs about change in directorate

01 Apr 2024 Evaluate
Anuh Pharma has informed that Jasvantlal Girdharlal Shah (DIN: 00372600), has completed his second and final term as an Independent Director and consequently ceased to be a Director of the Company with effective from the closure of business hours on 31st March, 2024. The Board of Directors and the Management of the Company expressed deep appreciation and gratitude to Jasvantlal Girdharlal Shah for his extensive contribution and stewardship. The details in respect of Jasvantlal Girdharlal Shah, as required under SEBI Regulations read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated 13th July 2023 is given in Annexure A to this letter.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1851.50
Dr. Reddys Labs. 1162.80
Cipla 1358.65
Lupin 2084.00
Zydus Lifesciences 1118.65
View more..